H J Cloft1, T Kaufmann, D F Kallmes. 1. Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA. cloft.harry@mayo.edu
Abstract
BACKGROUND AND PURPOSE: Assessments of completeness of endovascular cerebral aneurysm therapy are commonly reported in the literature. We studied several aneurysm assessment scales with regard to observer variability, which directly affects validity of these scales. MATERIALS AND METHODS: Initial aneurysm occlusion and occlusion at a follow-up angiogram at 3-6 months were assessed independently by 2 experienced observers. Assessments of each aneurysm were made using 3 different scales: 4-response (complete, dog ear, neck remnant, incomplete), 3-response (complete, near-complete, incomplete), and 2-response (complete or near-complete, incomplete). Assessments were also made of comparisons of initial treatment angiogram with follow-up angiogram using 2 different scales: 3-response (better, same, worse) and 2-point response (not worse, worse). RESULTS: With assessments of both initial and follow-up angiograms, interobserver and intraobserver agreement was progressively worse with increasing response choices in the scales. Observer agreement on assessments of initial angiograms (kappa values 0.48-0.67) was worse than that for follow-up angiograms (kappa values 0.66-0.97). For the comparisons of the initial angiogram with the follow-up angiogram, there was worse observer agreement with the 3-response scale (kappa values 0.64-0.71) than with the 2-response scale (kappa values 0.78-0.89). CONCLUSION: Interobserver and intraobserver variability are inherent to assessment scales of completeness of cerebral aneurysm therapy. Observer variability is substantially better in scales that offer fewer observer responses. However, scales with fewer observer responses may not identify aneurysm subgroups that have differing risks of recurrence and/or rehemorrhage.
BACKGROUND AND PURPOSE: Assessments of completeness of endovascular cerebral aneurysm therapy are commonly reported in the literature. We studied several aneurysm assessment scales with regard to observer variability, which directly affects validity of these scales. MATERIALS AND METHODS: Initial aneurysm occlusion and occlusion at a follow-up angiogram at 3-6 months were assessed independently by 2 experienced observers. Assessments of each aneurysm were made using 3 different scales: 4-response (complete, dog ear, neck remnant, incomplete), 3-response (complete, near-complete, incomplete), and 2-response (complete or near-complete, incomplete). Assessments were also made of comparisons of initial treatment angiogram with follow-up angiogram using 2 different scales: 3-response (better, same, worse) and 2-point response (not worse, worse). RESULTS: With assessments of both initial and follow-up angiograms, interobserver and intraobserver agreement was progressively worse with increasing response choices in the scales. Observer agreement on assessments of initial angiograms (kappa values 0.48-0.67) was worse than that for follow-up angiograms (kappa values 0.66-0.97). For the comparisons of the initial angiogram with the follow-up angiogram, there was worse observer agreement with the 3-response scale (kappa values 0.64-0.71) than with the 2-response scale (kappa values 0.78-0.89). CONCLUSION: Interobserver and intraobserver variability are inherent to assessment scales of completeness of cerebral aneurysm therapy. Observer variability is substantially better in scales that offer fewer observer responses. However, scales with fewer observer responses may not identify aneurysm subgroups that have differing risks of recurrence and/or rehemorrhage.
Authors: John Thornton; Gerard M Debrun; Victor A Aletich; Qasim Bashir; Fady T Charbel; James Ausman Journal: Neurosurgery Date: 2002-02 Impact factor: 4.654
Authors: Jean Raymond; François Guilbert; Alain Weill; Stavros A Georganos; Louis Juravsky; Anick Lambert; Julie Lamoureux; Miguel Chagnon; Daniel Roy Journal: Stroke Date: 2003-05-29 Impact factor: 7.914
Authors: Yuichi Murayama; Yih Lin Nien; Gary Duckwiler; Y Pierre Gobin; Reza Jahan; John Frazee; Neil Martin; Fernando Viñuela Journal: J Neurosurg Date: 2003-05 Impact factor: 5.115
Authors: M H Schönfeld; V Schlotfeldt; N D Forkert; E Goebell; M Groth; E Vettorazzi; Y D Cho; M H Han; H-S Kang; J Fiehler Journal: Clin Neuroradiol Date: 2014-08-27 Impact factor: 3.649
Authors: T J Kaufmann; J Huston; H J Cloft; J Mandrekar; L Gray; M A Bernstein; J L Atkinson; D F Kallmes Journal: AJNR Am J Neuroradiol Date: 2009-12-17 Impact factor: 3.825
Authors: J S McDonald; R E Carter; K F Layton; J Mocco; J B Madigan; R G Tawk; R A Hanel; S S Roy; H J Cloft; A M Klunder; S H Suh; D F Kallmes Journal: AJNR Am J Neuroradiol Date: 2012-10-25 Impact factor: 3.825
Authors: M E Sprengers; J Schaafsma; W J van Rooij; M Sluzewski; G J E Rinkel; B K Velthuis; J C van Rijn; C B Majoie Journal: AJNR Am J Neuroradiol Date: 2008-06-26 Impact factor: 3.825